A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's DiseaseYu Nakamura, Akira Homma, Christine Strohmaier et al.|Dementia and Geriatric Cognitive Disorders Extra|2015Cited by 11
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort studyMasayuki Kanamori, Yoshitaka Narita, Yoshiteru Shimoda et al.|Neuro-Oncology Advances|2024Cited by 3